New patent for Novartis drug VIJOICE

Published on June 15, 2023

Annual Drug Patent Expirations for VIJOICE Vijoice is a drug marketed by Novartis and is included in one NDA. It is available from one supplier. There are two patents protecting…

The post New patent for Novartis drug VIJOICE appeared first on DrugPatentWatch - Make Better Decisions.

The post New patent for Novartis drug VIJOICE appeared first on Biotechblog.

Continue reading on website
Other news

Silver-doped glass fibers used as a potential treatment for wound healing, finds study

June 15, 2023
Researchers at the University of Birmingham have demonstrated that silver retains antimicrobial activity for longer when it is impregnated into 'bioactive glass', and shown for the first time how this promising combination delivers more long-lasting antimicrobial wound protection than conventional alternatives.

KLON3D Gemini – Revolutionizing 3D Scanning with Instantaneous Photogrammetry

June 15, 2023
The iPRODUCE Hackathon of 2023 showcased some remarkable projects, both offline and online. Among the winners, the online team ‘KLON3D’ emerged victorious with their groundbreaking idea called ‘Gemini’ – a 3D scan photobooth. This feature highlights the concept behind the winning entry, its differentiating factors, potential applications in various markets, and the benefits the team gained from pa